You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Bulk Pharmaceutical API Sources for GENTACIDIN


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for GENTACIDIN

Vendor Vendor Homepage Vendor Sku API Url
ChemMol ⤷  Get Started Free 2100038 ⤷  Get Started Free
Chembase.cn ⤷  Get Started Free 169214 ⤷  Get Started Free
Chembase.cn ⤷  Get Started Free 169616 ⤷  Get Started Free
Aurora Fine Chemicals LLC ⤷  Get Started Free A24.084.691 ⤷  Get Started Free
Ambinter ⤷  Get Started Free Amb22897236 ⤷  Get Started Free
3WAY PHARM INC ⤷  Get Started Free SWOT-81357 ⤷  Get Started Free
BenchChem ⤷  Get Started Free B3395327 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for GENTACIDIN

Last updated: July 30, 2025

Introduction
Gentamicin, a broad-spectrum aminoglycoside antibiotic, is widely used to treat severe Gram-negative bacterial infections. Its efficacy hinges on high-quality Active Pharmaceutical Ingredients (APIs), which are sourced globally. The supply chain for gentamicin APIs reveals a diverse landscape of manufacturers spanning multiple regions, each with varying standards, costs, and regulatory compliances. This analysis provides an in-depth overview of key bulk API sources for gentamicin, elucidating their geographic distribution, regulatory considerations, and implications for healthcare providers and pharmaceutical companies.


Global Landscape of Gentamicin API Suppliers

1. Indian Manufacturers
India stands as the preeminent global supplier of gentamicin API, accounting for the majority of it concentrated export volumes. Major Indian API producers operate under stringent quality standards, including WHO-GMP and USFDA approvals, ensuring compliance with international regulations.

  • Wockhardt Ltd.
    A leading Indian pharmaceutical company, Wockhardt operates a robust API manufacturing facility compliant with global standards, including WHO-GMP. Their gentamicin sulfate API is widely used in numerous international markets. Wockhardt emphasizes quality assurance, making it a preferred choice for generic formulations.

  • Hetero Drugs Ltd.
    As one of India’s prominent generic API manufacturers, Hetero provides high-quality gentamicin sulfate APIs. Their facilities adhere to regulatory norms, and the company has received various approvals, expanding their global reach, particularly in developing markets.

  • Aurobindo Pharma
    A significant player with extensive API manufacturing capabilities, Aurobindo supplies gentamicin sulfate APIs compliant with international standards. They focus on cost-effective production while maintaining quality, contributing to their strong export presence.

  • Glenmark Pharmaceuticals
    Known for innovation, Glenmark’s API manufacturing includes gentamicin sulfate, with facilities approved by leading regulatory agencies. Their API offerings meet quality benchmarks essential for safe pharmaceutical applications.

2. Chinese API Manufacturers
China’s API sector for gentamicin is expanding, driven by competitive pricing and manufacturing capacity. However, regulatory oversight varies significantly across producers.

  • Sichuan Kelun Pharmaceutical Co., Ltd.
    An emerging Chinese API manufacturer, Kelun’s gentamicin sulfate API is gaining recognition for cost competitiveness. While some facilities may lack full international accreditation, Kelun increasingly seeks GMP compliance to expand export opportunities.

  • Qingdao Hengyuan Pharmaceutical Co., Ltd.
    Focused on generic APIs, this firm supplies gentamicin sulfate APIs primarily to Asian markets. Their facilities have begun adopting stricter regulatory standards amid international scrutiny.

  • Shandong Ouming Pharmaceutical
    Offers gentamicin APIs at competitive prices. Despite variable regulatory adherence, some Chinese manufacturers have achieved COS (Certificate of Suitability) or other certification to access regulated markets.

3. European API Suppliers
While Europe’s share in gentamicin API supply is comparatively limited, certain manufacturers maintain high GMP standards suitable for regulated markets.

  • BASF SE
    One of the few European producers, BASF offers high-quality APIs, including gentamicin sulfate, with extensive compliance credentials. Their focus is on premium product lines suited for North American and European markets.

  • Aspen Pharmacare
    Based in South Africa but with significant European API supply operations, Aspen maintains rigorous quality standards, with some production sites licensed for high-grade APIs.

4. North American API Sources
North American manufacturers primarily focus on finished dosage forms rather than bulk API production due to manufacturing constraints and regulatory frameworks.

  • Hoffmann-La Roche and Pfizer are historically involved in API production, but their focus has shifted toward proprietary formulations, with limited API exports for generic gentamicin sulfate.

Regulatory and Quality Considerations

GMP Compliance and Certification
The authenticity and quality of gentamicin API are crucial. Regulatory agencies, including the USFDA, EMA, and WHO, emphasize Good Manufacturing Practice (GMP) adherence. Indian and European manufacturers often possess comprehensive certifications, ensuring consistent supply quality.

Certificates of Suitability (CoS)
European Pharmacopoeia (EP) and UK Mutual Recognition Agreements facilitate streamlined approval for API sources with CoS, enhancing market access.

Counterfeit and Quality Concerns
Chinese suppliers, while economically advantageous, occasionally face scrutiny over regulatory compliance and quality assurance. Rigorous qualification assessments are critical before sourcing from these entities to mitigate risks.

Market Dynamics and Supply Chain Impact

Price Trends
Cost efficiency from Chinese and Indian suppliers sustains competitive gentamicin API prices globally. Indian manufacturers dominate due to economies of scale and established quality systems.

Supply Security
Current geopolitical and regulatory tensions risk supply disruptions. Diversifying API sources enhances resilience but must consider regulatory compliance, especially for regulated markets.

Implications for Pharmaceutical Companies
Manufacturers sourcing gentamicin API must balance cost considerations with regulatory compliance and quality assurance. Strategic partnerships with GMP-certified suppliers mitigate risks and support regulatory approval processes for finished products.


Conclusion

The global sourcing landscape for gentamicin API is predominantly characterized by Indian manufacturers, supported by evolving Chinese production capacities. Indian suppliers offer a combination of cost advantages and regulatory adherence, making them primary choices for international markets. Chinese suppliers, while vibrant, require diligent verification of GMP status to ensure product quality. European and North American sources, although limited in size, serve high-end markets demanding the utmost regulatory compliance. The ongoing global supply chain shifts necessitate careful sourcing strategies aligning with quality standards and market demands.


Key Takeaways

  • Indian API manufacturers dominate the global gentamicin sulfate supply chain, providing reliable, cost-effective, and GMP-compliant APIs.
  • Chinese suppliers are expanding but require due diligence regarding regulatory compliance and quality assurance.
  • European and North American API sources focus on high-quality standards, suitable for regulated markets.
  • Ensuring GMP compliance and verifying Certificates of Suitability are critical for sourcing high-quality gentamicin APIs.
  • Diversification of supply sources mitigates geopolitical and regulatory risks, ensuring a stable supply chain for pharmaceutical companies.

FAQs

1. What are the main regions supplying bulk gentamicin API globally?
Primarily India and China dominate, with European and North American sources playing niche roles in high-regulatory markets.

2. How can pharmaceutical companies verify the quality of gentamicin APIs from Chinese suppliers?
Through diligent review of GMP certifications, Certificates of Suitability, and on-site audits, alongside third-party quality assessments.

3. What regulatory standards should API suppliers for gentamicin meet?
Suppliers should comply with WHO-GMP, USFDA, EMA standards, and ideally possess Certificates of Suitability for seamless integration into regulated markets.

4. Why is quality assurance critical in sourcing gentamicin API?
Substandard APIs can lead to safety issues, regulatory non-compliance, product recalls, and damage to brand reputation.

5. Are there any emerging trends in gentamicin API sourcing?
Yes, increasing emphasis on GMP compliance in Chinese manufacturing, diversification away from China to India, and rising regulatory scrutiny are shaping sourcing strategies.


Sources
[1] WHO, "WHO Global Model Regulatory Framework for Medical Products," 2014.
[2] USFDA, "API Certification and Inspection," 2022.
[3] Indian Pharmaceutical Alliance Reports, 2022.
[4] European Pharmacopoeia, "Guidelines for API Quality," 2021.
[5] Industry market analyses, IQVIA, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.